Scientist at a microscope, by DefenceImages on Flickr
A new study of the funding awarded to antimicrobial resistance research projects in the UK calls for political leadership and sustained and targeted spending. Although emergence of antimicrobial resistance severely threatens our future ability to treat many infections, the UK infection-research spend targeting this important area is still unacceptably small, say a team of researchers led by Michael Head (UCL Infection and Population Health). The study is published online today in the Journal of Antimicrobial Chemotherapy . This study is the first systematic analysis of research funding for infectious disease research, and for antimicrobial resistance, in the UK between 1997 and 2010. There were 6,165 studies identified that were funded during the 14 year period, covering all infectious disease research, representing a total investment of £2.6 billion. Of those studies, 337 studies were funded for antimicrobial resistance research, comprising 5.5% of total infectious disease research projects. These were awarded £102 million; only 3.9% of the total spend, with a median award of approximately £120,000.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
